Kromek Group PLC (AIM:KMK) has won a £1.7 million Home Office contract to supply wearable radiation detectors as part of a national security programme. It’s the first order under a major UK radiological detection framework running to 2028.
Anglo Asian Mining Plc (LSE:AAZ, OTC:AGXKF) has started production at its new Demirli copper mine in Azerbaijan, the second new mine to enter production this year. It’s targeting 15,000 tonnes a year by 2026 as part of its push to become a mid-tier copper producer.
Imaging Biometrics Ltd (LSE:IBAI, OTCQB:IQAIF) has soft-closed its glioblastoma trial after hitting enrolment targets and will now prep for a phase II study. The once-daily oral drug has shown good safety so far, and final results are on the way.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has kept full-year revenue steady at £55 million and says it’s heading into a big year. Its peanut allergy trial is wrapping up, and it’s also eyeing a 2026 launch for its grass allergy treatment.
Creo Medical Group PLC (AIM:CREO) saw a 40% revenue jump in its core products and expects up to 60% growth in full-year core technology revenue. New US reimbursement codes and FDA clearances are helping drive adoption of its advanced surgical tools.
Vaultz Capital PLC (AQSE:V3TC) has added 20 more Bitcoin to its treasury, spending nearly £1.8 million. It’s also secured 20 PH/s ( petahashes per second) of cloud-based hashrate capacity, equivalent to approximately 200 mining units.
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.